How Tamiflu care of us.

Tamiflu: uses Tamiflu is used to treat symptoms caused by flu virus ( influenza ) . It helps make the symptoms ( e. g. , stuffy nose, cough, sore throat, fever/chills, aches, tiredness ) less severe and shortens the recovery time by 1-2 days. Tamiflu is also used to prevent flu if you have been exposed to someone who already has flu ( e. g. , sick household member ) .

Tamiflu works by stopping the flu virus from growing. It's not a substitute for the flu vaccine. ( See Notes )

Tamiflu shouldn't be used in infants younger than 1 year of age. Consult your doctor or pharmacist for more details.

Tamiflu: how to use Read Patient Information Leaflet available from your pharmacist before you start taking this medicine. If we have any questions, consult your doctor or pharmacist.

Take Tamiflu by mouth as directed by your doctor. We may take it with food or milk to minimize stomach upset. Take this medication as soon as flu symptoms appear or as soon as possible after we have been exposed to the flu. Tamiflu works best if we start taking it within 2 days of either of these events.

If we have flu, take Tamiflu usually twice a day for 5 days, or as directed by your doctor.

To prevent flu, take Tamiflu usually once a day for at least 10 days, or as directed by your doctor. Follow your doctor's instructions for how long to take this medicine.

Tamiflu works best when amount of medicine in your body is kept at a constant level. Therefore, take Tamiflu at evenly spaced intervals at same time ( s ) every day. Continue to take it for full time prescribed. Stopping medication too early may allow virus to continue to grow, which may result in a relapse of infection or failure to protect we from the flu.

Inform your doctor if your condition persists or worsens or if new symptoms appear.

Tamiflu: side effects Nausea and vomiting may occur while use Tamiflu as your body adjusts to this medication and usually go away after 1-2 days. Dizziness may also occur. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.

Remember that your doctor has prescribed Tamiflu because he or she has judged that benefit to we is greater than the risk of side effects. Many people using Tamiflu do not have serious side effects.

Tamiflu may rarely cause serious mental/mood changes. This may be more likely in children. Tell your doctor immediately of any signs of unusual behavior including confusion, agitation, self-injury.

Tell your doctor immediately if any of these rare but very serious side effects occur:

A very serious allergic reaction to Tamiflu is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction may include:

This isn't a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

Tamiflu: precautions Before taking Tamiflu, tell your doctor or pharmacist if we are allergic to it; or if we have any other allergies.

Before using Tamiflu, tell your doctor or pharmacist your medical history, especially of:

Tamiflu may make you dizzy; use caution engaging in activities requiring alertness such as driving or using machinery. Limit alcoholic beverages.

Tamiflu should be used only when clearly needed during pregnancy. Discuss risks and benefits with your doctor.

It's not known if Tamiflu passes into breast milk. Consult your doctor before breast-feeding.

Tamiflu: interactions Your healthcare professionals ( e. g. , doctor or pharmacist ) may already be aware of any possible drug interactions and may be monitoring we for it. Don't start, stop, or change dosage of any medicine before checking with them first.

Before using Tamiflu, tell your doctor or pharmacist of all prescription and nonprescription/herbal products we may use especially of:

Tell your doctor if we have received flu vaccine in nose within 2 weeks before treatment with Tamiflu. Tamiflu may lower your protection from flu vaccine given in the nose. Wait at least 2 days after ending treatment with Tamiflu before receiving flu vaccine given in nose.

This document doesn't contain all possible interactions. Therefore, before using Tamiflu, tell your doctor or pharmacist of all the products we use. Keep a list of all your medications with you, and share list with your doctor and pharmacist.

Tamiflu: overdose If overdose of Tamiflu is suspected, contact your local poison control center or emergency room immediately. US residents can call US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly.

Tamiflu: notes Don't share Tamiflu with others.

Tamiflu isn't a substitute for flu vaccine. Consult your doctor about the risks and important benefits of receiving a yearly flu shot to lower your chances of getting flu.

Tamiflu: missed dose If we miss a dose Tamiflu, use it as soon as we remember. If it's within 2 hours of your next dose, skip missed dose and resume your usual dosing schedule. Don't double dose of Tamiflu to catch up.

Tamiflu: storage Store Tamiflu at room temperature ( 77 degrees F or 25 degrees C ) away from light and moisture. Brief storage between 59-86 degrees F ( 15-30 degrees C ) is permitted. Do not store Tamiflu in bathroom. Keep all medicines away from children and pets.

Properly discard Tamiflu when it is expired or no longer needed. Consult your pharmacist or local waste disposal company for more details about how to safely discard your product.

Tamiflu with EU shipping

NAFLD AND NASH Linked To Metabolic Syndrome And Cardiovascular Disease

Data presented at today's sessions of the 43rd Annual Meeting of European Association for Study of Liver ( EASL ) further confirm that nonalcoholic fatty liver disease ( NAFLD ) and its most severe form, nonalcoholic steatohepatitis ( NASH ) , are associated with metabolic syndrome and pose an increased risk of cardiovascular disease.

NAFLD and NASH are significant health problems that affect millions of people worldwide, especially in Western countries. NAFLD is a fatty accumulation in liver that doesn't result from excessive use of alcohol. When this condition progresses, and is associated with inflammation and liver damage, it is then called NASH, which is thought to occur in 15% to 25% of cases of NAFLD. NASH is clearly associated with risk of developing liver cirrhosis, and its complications, including hepatocellular carcinoma, the most frequent primary tumour of liver. NASH-related cirrhosis is an increasingly occurring indication for liver transplantation.

In turn, metabolic syndrome is a combination of risk factors, including high blood lipids, abdominal obesity, and a tendency to diabetes. The association between NAFLD, NASH, and metabolic syndrome is a great cause for concern because people with metabolic syndrome are at increased risk for type 2 diabetes and cardiovascular disease, including heart attack and stroke.

According to Doctor Fabio Marra, Associate Professor of Medicine at University of Florence, " When I see a patient with a fatty liver, I have to consider all other risk factors for cardiovascular diseases and try to intervene aggressively to limit effects of those other factors, because accumulating data indicate that fatty liver may be itself an additional risk factor. '

The precise prevalence of NAFLD and NASH within individual countries is elusive. Large scale epidemiological studies are still needed, and definitive laboratory tests to identify patients with NASH are unavailable. At present, a biopsy of liver is only accepted diagnostic method. Despite these limitations, best current estimates suggest that in the general population NAFLD can be found in one-fourth to one-third of adults in Western countries. One U. S. study of children who died as a result of accidents found that 13% had NAFLD.

While a number of risk factors have been identified, foregoing percentages rise most dramatically among people who are obese. For example, studies have found NAFLD in 84% to 96% of patients undergoing bariatric surgery. For these reasons, NAFLD and NASH are seen to be increasing as poor dietary habits and sedentary lifestyles become more widespread.

Although NAFLD and NASH haven't to date been included as components of metabolic syndrome, increasingly onset of NAFLD is being viewed by experts as an early event in development of insulin resistance and therefore as an indicator or predictor of future metabolic syndrome.

Among key unanswered questions: Why do some people with NAFLD live out their lives unaffected by their condition of having a fatty liver, while others go on to develop NASH and cirrhosis, or diabetes and/or cardiovascular disease?

At present, there are no specific therapies for NASH. Among chief recommendations offered to patients are to lose weight gradually ( particularly if one is obese ) and to increase physical activity, to eat a healthy diet, and to avoid alcohol.

About EASL

The European Association for the Study of Liver ( EASL ) aims to promote investigation into liver disease and improve treatments that currently exist for these conditions. The association, through its annual meetings, seeks to inform and educate both scientific community as well as society in general about increasing occurrence of liver diseases along with importance of understanding these conditions in order to treat and prevent them. Since its creation in 1966, EASL congress has been hosted in 20 different European countries. Currently association has over 1400 members and the annual congress attracts over 6000 delegates from over 65 countries each year.

European Association for Study of Liver http: //www. easl. ch

Affordable prices for teeth porcelain laminates at Prague, Czech republic dental clinic